Talking Medicines: Funding, Investors & Team (Sep 2026)
Data tech innovator Talking Medicines, based in Glasgow and London, uses advanced AI and ML to provide pharmaceutical companies with real-time data intelligence. The company uses a collection of AI, ML and NLP tech tools to capture and structure the voice of the patient from real world conversations and behaviours at home. Through mapping the patient voice from social media and connected devices to regulated medicine information, the company is able to build data points to deliver trends and patterns of patient sentiment across medicines. This intelligence embraces regulatory compliance enabling marketing in pharmaceutical companies to measure patient confidence by medicine and in turn action the levers for share growth.
Talking Medicines has raised $2.4M across 2 funding rounds on record, the most recent an undisclosed round of $360k announced in May 2026.
That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Talking Medicines Company Profile and Key Stats
Latest funding round on record: May 2026.
Talking Medicines Funding Rounds
Talking Medicines raised $2.0M in an undisclosed round announced in Feb 2022.
4.3 years later, an undisclosed round of $360k was announced in May 2026.
Talking Medicines Founders and Leadership Team
Contact details for the Talking Medicines team: 1 of 1 has an email address on file.
Start 14-day free trial →Talking Medicines Funding Compared to Other Artificial Intelligence Startups
Talking Medicines' latest round of $360k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Talking Medicines in Artificial Intelligence and Glasgow
Companies Similar to Talking Medicines
Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…
Callosum provides data analytics, artificial intelligence, and digital engineering services for data…
Medly AI is an advanced tutor that is able to support students in multiple languages through the use of…
Mindgard is an AI security company that assists businesses in safeguarding their AI models against cyber…
Edgify is a developer of a predictive personalization technology used to analyze a user's photos on their…
The AI agents provided by Finster AI possess the ability to comprehend, evaluate, and incorporate various…
Malted AI is a company that designs a low-code platform that allows businesses to create and launch…
OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial…
Qureight is a company specializing in imaging analytics, with a goal of enhancing its analytical platform to…
Greyparrot is the leading AI waste analytics platform for the circular economy. We are on a mission to…
Founded by Dr. Sam Tukra and Callum Adamson (who have been working together since 2019) in 2023 to solve the…
1001 AI is a deep-tech artificial intelligence startup that develops AI infrastructure and…
Talking Medicines Funding FAQs
What does Talking Medicines do?
Data tech innovator Talking Medicines, based in Glasgow and London, uses advanced AI and ML to provide pharmaceutical companies with real-time data intelligence. The company uses a collection of AI, ML and NLP tech tools to capture and structure the voice of the patient from real world conversations and behaviours at home. Through mapping the patient voice from social media and connected devices to regulated medicine information, the company is able to build data points to deliver trends and patterns of patient sentiment across medicines. This intelligence embraces regulatory compliance enabling marketing in pharmaceutical companies to measure patient confidence by medicine and in turn action the levers for share growth.
How much funding has Talking Medicines raised?
Talking Medicines has raised $2.4M across 2 rounds on record. The most recent is an undisclosed round of $360k announced in May 2026.
When did Talking Medicines last raise funding?
Talking Medicines' most recent funding round on record is an undisclosed round of $360k, announced in May 2026.
Who is the CEO of Talking Medicines?
Jo Halliday is listed as CEO at Talking Medicines.
Where is Talking Medicines headquartered?
Talking Medicines is based in Glasgow, United Kingdom.
How many employees does Talking Medicines have?
Talking Medicines is in the 11-50 employee band.
How does Talking Medicines' funding compare to other Artificial Intelligence startups?
Talking Medicines' latest round of $360k is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Talking Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Talking Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.